ERYtech Pharma, a specialty pharma company located in France and in USA (Philadelphia), is pleased to announce a collaborative research agreement in the field of personalized medicine focusing on ERYtech's flagship product, GRASPA®, which consists of red blood cell-encapsulated L-asparaginase (L-ASP). Pr. John Weinstein, Chair of the Department of Bioinformatics and Computational Biology at M.D... 
More...
More...